These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3924827)

  • 61. Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes.
    Robinson P; Wakefield D; Breit SN; Easter JF; Penny R
    Infect Immun; 1984 Feb; 43(2):744-52. PubMed ID: 6693174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Solubilization of immune precipitates by six isolated alternative pathway proteins.
    Fujita T; Takata Y; Tamura N
    J Exp Med; 1981 Dec; 154(6):1743-51. PubMed ID: 6459396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.
    Cryz SJ; Pitt TL; Fürer E; Germanier R
    Infect Immun; 1984 May; 44(2):508-13. PubMed ID: 6425224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
    Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Complement and bacteria: chemistry and biology in host defense.
    Joiner KA; Brown EJ; Frank MM
    Annu Rev Immunol; 1984; 2():461-91. PubMed ID: 6399850
    [No Abstract]   [Full Text] [Related]  

  • 66. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae.
    Liang-Takasaki CJ; Saxén H; Mäkelä PH; Leive L
    Infect Immun; 1983 Aug; 41(2):563-9. PubMed ID: 6347890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
    Taylor PW
    Microbiol Rev; 1983 Mar; 47(1):46-83. PubMed ID: 6343827
    [No Abstract]   [Full Text] [Related]  

  • 68. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
    Fries LF; Gaither TA; Hammer CH; Frank MM
    J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length.
    Grossman N; Leive L
    J Immunol; 1984 Jan; 132(1):376-85. PubMed ID: 6197450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
    Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
    J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Tsai CM; Frasch CE
    Anal Biochem; 1982 Jan; 119(1):115-9. PubMed ID: 6176137
    [No Abstract]   [Full Text] [Related]  

  • 74. Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections.
    Geuze HJ; Slot JW; van der Ley PA; Scheffer RC
    J Cell Biol; 1981 Jun; 89(3):653-65. PubMed ID: 6166621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages.
    Liang-Takasaki CJ; Mäkelä PH; Leive L
    J Immunol; 1982 Mar; 128(3):1229-35. PubMed ID: 6120195
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
    Young LS; Armstrong D
    J Infect Dis; 1972 Sep; 126(3):257-76. PubMed ID: 4626509
    [No Abstract]   [Full Text] [Related]  

  • 77. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. II. Interaction of opsonins with the phagocytic cell.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S127-31. PubMed ID: 4214224
    [No Abstract]   [Full Text] [Related]  

  • 78. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
    [No Abstract]   [Full Text] [Related]  

  • 79. Influence of the alternate complement pathway in opsonization of several bacterial species.
    Forsgren A; Quie PG
    Infect Immun; 1974 Aug; 10(2):402-4. PubMed ID: 4152919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of extracellular protease production in Bacillus cereus T: characterization of mutants producing altered amounts of protease.
    Aronson AI; Angelo N; Holt SC
    J Bacteriol; 1971 Jun; 106(3):1016-25. PubMed ID: 4104235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.